Answers are grounded in this paper and cite their sources.
Laboratory study shows altered cerebral blood flow correlates with acute mountain sickness symptoms, indicating significant physiological responses.
People who climb high altitudes frequently experience headaches, which are the primary symptoms of acute mountain sickness (AMS). While headaches and AMS are primarily caused by hypoxia, they remain poorly understood, specifically, the effects of regional cerebral blood flow on headache and AMS. In this high-altitude laboratory study, we investigated the hypothesis that regional cerebrovascular responses to high-altitude (3,776 m) sojourns are associated with AMS symptoms. The internal carotid artery (ICA), vertebral artery (VA), cardiorespiratory and vascular responses, and symptoms of AMS were assessed in eight healthy male lowlanders (mean age, 34 years) at sea level (SL, 450 m) and on three consecutive days at the summit of Mount Fuji (3,776 m). Compared to sea level, ICA flow increased on day 3 ( P = 0.009) and ICA diameter increased on days 1 to 3 ( P <0.001). In contrast, VA flow increased on days 1 and 2 ( P = 0.008 and P = 0.018) and VA velocity increased on day 1 ( P = 0.044). Headaches increased over the 3 days ( P = 0.011 to P = 0.048) but AMS increased on day 3 ( P = 0.001). Repeated-measures correlation analysis revealed that changes in headaches from the previous day were correlated with percent changes in ICA diameter ( r rm = 0.596, P = 0.012), VA flow and velocity ( r rm = 0.537, P = 0.026; r rm = 0.619, P = 0.008). Thus, a high-altitude-induced increase in cerebrovascular perfusion may contribute to the worsening of headaches, which is a typical AMS pathogenesis.
No takes yet. Share an insight, caveat, or question.
Okazaki et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: